Literature DB >> 6438221

Congenital goitrous hypothyroidism: discordant systolic time intervals, pituitary and peripheral responses to high daily doses of T4 or T3 therapy.

H Cavaliere, R Savioli, E Lima, G A Medeiros-Neto.   

Abstract

Left ventricular performance was studied by a noninvasive technique through the measurement of the systolic time intervals (total eletromechanical systole, left ventricular ejection (LVET) time, preejection period (PEP) and PEP/LVET ratio (Systolic Quotient) in 8 young adults with congenital goitrous hypothyroidism. All subjects showed lengthening of PEP, shortening of LVET and an increased PEP/LVET ratio associated with low serum T3 and T4, an exaggerated TSH response to TRH, high levels of serum cholesterol, triglycerides and carotene. They were treated with increasing L-T4 at monthly intervals (100, 200 and 400 micrograms daily), followed by L-T3 (50 and 200 micrograms daily) after stopping medication for another month. Systolic time intervals and the systolic quotient promptly reversed to the normal range with physiologic L-T4 (100 micrograms) or L-T3 (50 micrograms) replacement, but the TSH peak response to TRH was still present and exaggerated. Further reductions of the systolic quotient occurred with 200 micrograms L-T4, but not with supraphysiological doses (400 micrograms L-T4 or 200 micrograms L-T3) of thyroid hormones. The highest dose of L-T3 (200 micrograms/day) induced a significantly lower mean systolic quotient than 400 micrograms L-T4 daily, while 5 patients still had a significant TSH response to TRH. This was interpreted as discordant pituitary and cardiac response to L-T3 and L-T4 therapy. Serum cholesterol and triglycerides were considered as very sensitive index of thyroid hormone peripheral action. These had a significant positive correlation with changes in the left ventricular performance. Serum carotene, although decreasing significantly with L-T4 or L-T3 treatment, had no significant correlation with the systolic quotient.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6438221     DOI: 10.1007/bf03351018

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  A critical review of the systolic time intervals.

Authors:  R P Lewis; S E Rittogers; W F Froester; H Boudoulas
Journal:  Circulation       Date:  1977-08       Impact factor: 29.690

Review 2.  Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications.

Authors:  P R Larsen; J E Silva; M M Kaplan
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

3.  Cardiac systolic time intervals in thyroid disorders.

Authors:  E L Mazzaferri; R P Lewis
Journal:  Arch Intern Med       Date:  1978-10

4.  Improved diagnosis and management of hyper- and hypothyroidism by timing the arterial sounds.

Authors:  R T Young; A J Van Herle; D Rodbard
Journal:  J Clin Endocrinol Metab       Date:  1976-02       Impact factor: 5.958

5.  Plasma triglyceride metabolism in thyroid disease.

Authors:  E A Nikkilä; M Kekki
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

6.  Congenital goitre and hypothyroidism with impaired iodide organification and high thyroid peroxidase concentration.

Authors:  G A Medeiros-Neto; T Nakashima; A Taurog; M Knobel; J P Simonetti; E Mattar
Journal:  Clin Endocrinol (Oxf)       Date:  1979       Impact factor: 3.478

7.  Distribution and metabolism of L- and D-triiodothyronine (T3) in the rat: preferential accumulation of L-T3 by hepatic and cardiac nuclei as a probable explanation of the differential biological potency of T3 enantiomers.

Authors:  H L Schwartz; D Trence; J H Oppenheimer; N S Jiang; D B Jump
Journal:  Endocrinology       Date:  1983-10       Impact factor: 4.736

8.  Pituitary nuclear 3,5,3'-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine.

Authors:  J E Silva; P R Larsen
Journal:  Science       Date:  1977-11-11       Impact factor: 47.728

9.  Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement.

Authors:  W F Crowley; E C Ridgway; E W Bough; G S Francis; G H Daniels; I A Kourides; G S Myers; F Maloof
Journal:  N Engl J Med       Date:  1977-01-06       Impact factor: 91.245

10.  Therapy of primary hypothyroidism with L-triiodothyronine: discordant cardiac and pituitary responses.

Authors:  E C Ridgway; D S Cooper; H Walker; G H Daniels; W W Chin; G Myers; F Maloof
Journal:  Clin Endocrinol (Oxf)       Date:  1980-11       Impact factor: 3.478

View more
  2 in total

1.  Persistent pituitary resistance to thyroid hormone in congenital versus later-onset hypothyroidism.

Authors:  H Cavaliere; G A Medeiros-Neto; W Rosner; I A Kourides
Journal:  J Endocrinol Invest       Date:  1985-12       Impact factor: 4.256

2.  Cardiac function in congenital hypothyroidism: impairment and response to L-T4 therapy.

Authors:  G Balducci; A Acquafredda; F Amendola; M Natuzzi; N Laforgia; L Cavallo
Journal:  Pediatr Cardiol       Date:  1991-01       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.